About: Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $38.78 (-0.87%)
CLDXNASDAQCelldex Therapeutics Inc
Celldex Therapeutics Inc share price
CLDX price activity
Last Price
$38.780
Change (24hr)
-0.34 USD (-0.87%)
Volume
587.78K
Volume (4w avg)
-
Open
$38.95
Day Range
$38.67 - $40.04
Previous Close
$39.12
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
CLDX price performance
Delayed
09 Sep, 8:00 pm GMT+0
CLDX Market Signals